130 related articles for article (PubMed ID: 34256891)
21. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate.
Ambrogi V; Perioli L; Marmottini F; Giovagnoli S; Esposito M; Rossi C
Eur J Pharm Sci; 2007 Nov; 32(3):216-22. PubMed ID: 17826966
[TBL] [Abstract][Full Text] [Related]
22. Drug delivery of amoxicillin molecule as a suggested treatment for covid-19 implementing functionalized mesoporous SBA-15 with aminopropyl groups.
Alazzawi HF; Salih IK; Albayati TM
Drug Deliv; 2021 Dec; 28(1):856-864. PubMed ID: 33928831
[TBL] [Abstract][Full Text] [Related]
23. A discriminating dissolution method for glimepiride polymorphs.
Bonfilio R; Pires SA; Ferreira LM; de Almeida AE; Doriguetto AC; de Araújo MB; Salgado HR
J Pharm Sci; 2012 Feb; 101(2):794-804. PubMed ID: 22052673
[TBL] [Abstract][Full Text] [Related]
24. Hollow mesoporous silica as a high drug loading carrier for regulation insoluble drug release.
Geng H; Zhao Y; Liu J; Cui Y; Wang Y; Zhao Q; Wang S
Int J Pharm; 2016 Aug; 510(1):184-94. PubMed ID: 27262268
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and surface modification of mesoporous silica nanoparticles and its application as carriers for sustained drug delivery.
Ahmadi E; Dehghannejad N; Hashemikia S; Ghasemnejad M; Tabebordbar H
Drug Deliv; 2014 May; 21(3):164-72. PubMed ID: 24116869
[TBL] [Abstract][Full Text] [Related]
26. How Molecular Mobility, Physical State, and Drug Distribution Influence the Naproxen Release Profile from Different Mesoporous Silica Matrices.
d'Orey P; Cordeiro T; Lourenço MAO; Matos I; Danède F; Sotomayor JC; Fonseca IM; Ferreira P; Correia NT; Dionísio M
Mol Pharm; 2021 Mar; 18(3):898-914. PubMed ID: 33461296
[TBL] [Abstract][Full Text] [Related]
27. Modified mesoporous silica nanoparticles for enhancing oral bioavailability and antihypertensive activity of poorly water soluble valsartan.
Biswas N
Eur J Pharm Sci; 2017 Mar; 99():152-160. PubMed ID: 27993684
[TBL] [Abstract][Full Text] [Related]
28. Characterization and therapeutic efficacy evaluation of glimepiride and L-arginine co-amorphous formulation prepared by supercritical antisolvent process: Influence of molar ratio and preparation methods.
Park H; Jin Seo H; Hong SH; Ha ES; Lee S; Kim JS; Baek IH; Kim MS; Hwang SJ
Int J Pharm; 2020 May; 581():119232. PubMed ID: 32240805
[TBL] [Abstract][Full Text] [Related]
29. Solid self-nanoemulsifying drug delivery system (S-SNEDDS) for oral delivery of glimepiride: development and antidiabetic activity in albino rabbits.
Mohd AB; Sanka K; Bandi S; Diwan PV; Shastri N
Drug Deliv; 2015; 22(4):499-508. PubMed ID: 24471856
[TBL] [Abstract][Full Text] [Related]
30. Development and Characterization of a Glimepiride-Loaded Gelatin-Coated Mesoporous Hollow Silica Nanoparticle Formulation and Evaluation of Its Hypoglycemic Effect on Type-2 Diabetes Model Rats.
Yu X; Liu T; Lin R
Assay Drug Dev Technol; 2020; 18(8):369-378. PubMed ID: 33136434
[No Abstract] [Full Text] [Related]
31. Tadalafil inclusion in microporous silica as effective dissolution enhancer: optimization of loading procedure and molecular state characterization.
Mehanna MM; Motawaa AM; Samaha MW
J Pharm Sci; 2011 May; 100(5):1805-18. PubMed ID: 21374616
[TBL] [Abstract][Full Text] [Related]
32. Preparation of a novel starch-derived three-dimensional ordered macroporous carbon for improving the dissolution rate and oral bioavailability of water-insoluble drugs.
Liu Y; Wu C; Hao Y; Xu J; Zhao Y; Qiu Y; Jiang J; Yu T; Ji P
J Pharm Biomed Anal; 2016 Jan; 118():267-275. PubMed ID: 26580824
[TBL] [Abstract][Full Text] [Related]
33. Optimization of tetracycline hydrochloride adsorption on amino modified SBA-15 using response surface methodology.
Hashemikia S; Hemmatinejad N; Ahmadi E; Montazer M
J Colloid Interface Sci; 2015 Apr; 443():105-14. PubMed ID: 25540827
[TBL] [Abstract][Full Text] [Related]
34. Molecular-level insight into hot-melt loading and drug release from mesoporous silica carriers.
Lizoňová D; Mužík J; Šoltys M; Beránek J; Kazarian SG; Štěpánek F
Eur J Pharm Biopharm; 2018 Sep; 130():327-335. PubMed ID: 30012403
[TBL] [Abstract][Full Text] [Related]
35. Chiral mesoporous silica synthesized by a facile strategy for loading and releasing poorly water-soluble drug.
Gao Z; Lv X; Fu Y; Zang X; Sun Y; Li S; Zhang H; Qiao S; Wang L; Sun Y
Drug Dev Ind Pharm; 2020 Jul; 46(7):1177-1184. PubMed ID: 32538184
[TBL] [Abstract][Full Text] [Related]
36. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R
Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939
[TBL] [Abstract][Full Text] [Related]
37. Biomimetic synthesis and evaluation of histidine-derivative templated chiral mesoporous silica for improved oral delivery of the poorly water-soluble drug, nimodipine.
Li H; Li H; Wei C; Ke J; Li J; Xu L; Liu H; YangYang ; Li S; Yang M
Eur J Pharm Sci; 2018 May; 117():321-330. PubMed ID: 29530545
[TBL] [Abstract][Full Text] [Related]
38. Development and evaluation of hollow mesoporous silica microspheres bearing on enhanced oral delivery of curcumin.
Gao Y; Ding S; Huang X; Fan Z; Sun J; Hai Y; Li K
Drug Dev Ind Pharm; 2019 Feb; 45(2):273-281. PubMed ID: 30346852
[TBL] [Abstract][Full Text] [Related]
39. Ordered mesoporous silica material SBA-15: loading of new calcium channel blocker--lacidipine.
Kiwilsza A; Mielcarek J; Pajzderska A; Wąsicki J
J Microencapsul; 2013; 30(1):21-7. PubMed ID: 22676483
[TBL] [Abstract][Full Text] [Related]
40. Mesoporous silica nanoparticles as potential carriers for enhanced drug solubility of paclitaxel.
He Y; Liang S; Long M; Xu H
Mater Sci Eng C Mater Biol Appl; 2017 Sep; 78():12-17. PubMed ID: 28575958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
